HCA Healthcare, Inc. (HCA) To Go Ex-Dividend on September 15th

HCA Healthcare, Inc. (NYSE:HCA) announced a quarterly dividend on Tuesday, July 20th, RTT News reports. Shareholders of record on Thursday, September 16th will be given a dividend of 0.48 per share on Thursday, September 30th. This represents a $1.92 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date is Wednesday, September 15th.

Shares of NYSE HCA opened at $249.25 on Thursday. HCA Healthcare has a one year low of $114.38 and a one year high of $254.45. The firm has a market capitalization of $82.41 billion, a price-to-earnings ratio of 17.10, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63. The company has a fifty day moving average price of $212.68. The company has a quick ratio of 1.15, a current ratio of 1.45 and a debt-to-equity ratio of 18.06.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Monday, July 19th. The company reported $4.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.16 by $1.21. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The firm had revenue of $14.44 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period in the prior year, the company posted $3.23 earnings per share. The business’s revenue for the quarter was up 30.4% compared to the same quarter last year. On average, equities analysts anticipate that HCA Healthcare will post 16.7 EPS for the current year.

A number of research firms have recently issued reports on HCA. The Goldman Sachs Group lifted their target price on shares of HCA Healthcare from $223.00 to $252.00 and gave the company a “buy” rating in a research note on Monday. Truist Securities boosted their price objective on HCA Healthcare from $200.00 to $230.00 and gave the stock a “buy” rating in a research note on Wednesday, April 14th. TheStreet cut HCA Healthcare from a “b” rating to a “c+” rating in a report on Tuesday. Citigroup upped their target price on shares of HCA Healthcare from $215.00 to $268.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating and set a $218.00 price objective on the stock. in a research report on Tuesday, June 15th. Four equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $231.48.

In other news, insider A Bruce Moore, Jr. sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, May 3rd. The stock was sold at an average price of $205.32, for a total transaction of $2,463,840.00. Following the sale, the insider now owns 102,381 shares in the company, valued at approximately $21,020,866.92. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Robert A. Waterman sold 72,845 shares of the business’s stock in a transaction on Wednesday, April 28th. The stock was sold at an average price of $199.85, for a total transaction of $14,558,073.25. Following the transaction, the senior vice president now owns 270,090 shares in the company, valued at $53,977,486.50. The disclosure for this sale can be found here. Insiders have sold a total of 342,446 shares of company stock worth $68,773,585 over the last three months. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also: Investing in Dividend Stocks

Dividend History for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.